Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma

Santofimia-Castaño, P. ; Xia, Y. ; Peng, L. ; Velázquez-Campoy, A. (Universidad de Zaragoza) ; Abián, O. (Universidad de Zaragoza) ; Lan, W. ; Lomberk, G. ; Urrutia, R. ; Rizzuti, B. ; Soubeyran, P. ; Neira, J.L. ; Iovanna, J.

Resumen: Cancer cells activate stress-response mechanisms to adapt themselves to a variety of stressful conditions. Among these protective mechanisms, those controlled by the stress-induced nuclear protein 1 (NUPR1 ) belong to the most conserved ones. NUPR1 is an 82-residue-long, monomeric, basic and intrinsically disordered protein (IDP), which was found to be invariably overexpressed in some, if not all, cancer tissues. Remarkably, we and others have previously showed that genetic inactivation of the Nupr1 gene antagonizes the growth of pancreatic cancer as well as several other tumors. With the use of a multidisciplinary strategy by combining biophysical, biochemical, bioinformatic, and biological approaches, a trifluoperazine-derived compound, named ZZW-115, has been identified as an inhibitor of the NUPR1 functions. The anticancer activity of the ZZW-115 was first validated on a large panel of cancer cells. Furthermore, ZZW-115 produced a dose-dependent tumor regression of the tumor size in xenografted mice. Mechanistically, we have demonstrated that NUPR1 binds to several importins. Because ZZW-115 binds NUPR1 through the region around the amino acid Thr68, which is located into the nuclear location signal (NLS) region of the protein, we demonstrated that treatment with ZZW-115 inhibits completely the translocation of NUPR1 from the cytoplasm to the nucleus by competing with importins.

Idioma: Inglés

DOI: 10.3390/cells8111453

Año: 2019

Publicado en: Cells 8, 11 (2019), 1453 [9 pp]
ISSN: 2073-4409

Factor impacto JCR: 4.366 (2019)

Categ. JCR: CELL BIOLOGY rank: 70 / 194 = 0.361 (2019) - Q2 - T2

Financiación: info:eu-repo/grantAgreement/ES/DGA/B01
Financiación: info:eu-repo/grantAgreement/ES/DGA/B89
Financiación: info:eu-repo/grantAgreement/ES/FIS/PI15-00663
Financiación: info:eu-repo/grantAgreement/ES/FIS/PI18-00343
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CPII13-00017
Financiación: info:eu-repo/grantAgreement/ES/MINECO/BFU2016-78232-P

Tipo y forma: Revisión (Versión definitiva)

Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)